Coronary Interventions

Videos

Simone Biscaglia, Ajay J Kirtane, Kendra J Grubb, et al

ACC 22: 5 Trials That Will Change Your Practice with Interventionist, Dr Mirvat Alasnag

Mirvat Alasnag,

ACC 22: FFR vs. IVUS-guided PCI in Intermediate Coronary Artery Stenosis: The FLAVOUR Trial

Bon-Kwon Koo,

View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

USC Discussion: Hemodynamics in Cardiogenic Shock

Alexander G Truesdell, Jaime A Hernandez-Montfort, Varinder Kaur Randhawa, et al

View from the Thoraxcenter: TCT 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem,

View from the Thoraxcenter: AHA 21 Late-breaking Science Preview

Joost Daemen, Nicolas M Van Mieghem,

TCT 21: SCB Shows Similar Angiographic Outcomes to Paclitaxel DCB

Bruno Scheller,

TRISCEND II: 6Mo Outcomes Show TR Reduction in Majority of Patients

Susheel Kodali,

SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB

Rafael Romaguera,

iFR-SWEDEHEART: No Difference in Outcome at 5-yrs of iFR vs FFR

Matthias Gotberg,

FAME3: PCI Guided by FFR Didn't Meet Noninferiority for 1Y Outcomes Compared to CABG

William Fearon,

View from the Thoraxcenter: TCT 21 Late-breaking Science Preview

Joost Daemen, Nicolas M Van Mieghem,

View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem,

Cardio-oncology Discussion: Primary PCI in Cancer Patients

Arjun K Ghosh, Deepak L Bhatt, Cezar Iliescu, et al

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

George D Dangas,

STOPDAPT-2 ACT: 1-month DAPT Followed by Clopidogrel Monotherapy in ACS

Hirotoshi Watanabe,

TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI

Davide Cao,

SYNTAX II Trial: 5yr Data Shows Reduction in MACE in PCI

Adrian P Banning,

ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

View from the Thoraxcenter – What's Hot at ESC 2021

Joost Daemen, Nicolas M Van Mieghem,

Bill D Gogas, ,

USC Discussion: The MAIN-COMPARE Registry | Revascularization

Bill D Gogas, ,

Videos

Simone Biscaglia, Ajay J Kirtane, Kendra J Grubb, et al

ACC 22: 5 Trials That Will Change Your Practice with Interventionist, Dr Mirvat Alasnag

Mirvat Alasnag,

ACC 22: FFR vs. IVUS-guided PCI in Intermediate Coronary Artery Stenosis: The FLAVOUR Trial

Bon-Kwon Koo,

View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

USC Discussion: Hemodynamics in Cardiogenic Shock

Alexander G Truesdell, Jaime A Hernandez-Montfort, Varinder Kaur Randhawa, et al

OPTIMUM Registry: PCI in Patients at Prohibitive Risk for CABG

David Kandzari,

View from the Thoraxcenter: TCT 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem,

View from the Thoraxcenter: AHA 21 Late-breaking Science Preview

Joost Daemen, Nicolas M Van Mieghem,

TCT 21: SCB Shows Similar Angiographic Outcomes to Paclitaxel DCB

Bruno Scheller,

TRISCEND II: 6Mo Outcomes Show TR Reduction in Majority of Patients

Susheel Kodali,

SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB

Rafael Romaguera,

iFR-SWEDEHEART: No Difference in Outcome at 5-yrs of iFR vs FFR

Matthias Gotberg,

FAME3: PCI Guided by FFR Didn't Meet Noninferiority for 1Y Outcomes Compared to CABG

William Fearon,

View from the Thoraxcenter: TCT 21 Late-breaking Science Preview

Joost Daemen, Nicolas M Van Mieghem,

View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up

Joost Daemen, Nicolas M Van Mieghem,

Cardio-oncology Discussion: Primary PCI in Cancer Patients

Arjun K Ghosh, Deepak L Bhatt, Cezar Iliescu, et al

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

George D Dangas,

STOPDAPT-2 ACT: 1-month DAPT Followed by Clopidogrel Monotherapy in ACS

Hirotoshi Watanabe,

TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI

Davide Cao,

SYNTAX II Trial: 5yr Data Shows Reduction in MACE in PCI

Adrian P Banning,

ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

View from the Thoraxcenter – What's Hot at ESC 2021

Joost Daemen, Nicolas M Van Mieghem,

Bill D Gogas, ,

John Eikelboom, Ken Okumura, Jan Steffel, et al

USC Discussion: The MAIN-COMPARE Registry | Revascularization

Bill D Gogas, ,

The Right Snuffbox Approach

Yong Cheol Kim,

The Left Snuffbox Approach

Yong Cheol Kim,

EuroPCR 2019: OCT-based FFR - Prof Shengxian Tu

Shengxian Tu,

TCT 2018: ULTIMATE

Jun Jie-Zhang,

Articles

APSC Consensus Recommendations for MitraClip in MR

Khung Keong Yeo

,

Jack Wei Chieh Tan

,

David WM Muller

,

Darren L Walters

,

JoAnn Lindenfeld

,

Michael Kang-Yin Lee

,

Angus Shing Fung Chui

,

Sai Satish

,

Teguh Santoso

,

Shunsuke Kubo

,

John Chan Kok Meng

,

Kenny YK Sin

,

See Hooi Ewe

,

David Sim

,

Edgar Tay

,

Krissada Meemook

,

Shih-Hsien Sung

,

Quang Ngoc Nguyen

,

Xiangbin Pan

,

Makoto Amaki

,

Masaki Izumo

,

Kentaro Hayashida

,

Jung Sun Kim

,

Do-Yoon Kang

,

Gregg Stone

,

Takashi Matsumoto

,

Published:

01 June 2021

Citation:

European Cardiology Review 2021;16:e25.

DOI:

https://doi.org/10.15420/ecr.2021.01
  • Views: Views 2185
  • Downloads: Downloads 151

Pathology of First-generation Drug-eluting Stents in Humans

Fumiyuki Otsuka

,

Masataka Nakano

,

Saami K Yazdani

,

Elena Ladich

,

Frank D Kolodgie

,

Renu Virmani

,

Citation:

Asia-Pacific Cardiology 2011;3(1):52-9

DOI:

https://doi.org/10.15420/apc.2011:3:1:52
  • Views: Views 152
  • Downloads: Downloads 3

Non-cardiac Surgery Following Drug-eluting Stents

Dev Pahlajani

,

Citation:

Asia-Pacific Cardiology 2007;1(1):40-1

DOI:

https://doi.org/10.15420/apc.2007:1:1:40
  • Views: Views 768
  • Downloads: Downloads 0

Limus-eluting Stents with Poly-L-lactic Acid Coating

Junbo Ge

,

Citation:

Asia-Pacific Cardiology 2007;1(1):42-3

DOI:

https://doi.org/10.15420/apc.2007:1:1:42
  • Views: Views 756
  • Downloads: Downloads 2